Cardiologists find a novel use for pacemakers
This article was originally published in Clinica
Executive Summary
A multinational group of cardiologists says pacemakers can be used to treat hypertrophic obstructive cardiomyopathy (HOCM), a disease which can strike at any age and is the most common cause of sudden death in athletes. HOCM is caused by the thickening of the heart's ventricular walls. Eventually the thickening obstructs the flow of blood so much that the left ventricle can no longer satisfy the body's need for oxygen.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.